![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/26 | |
A61P 3/04 |
(11) | Number of the document | 2866825 |
(13) | Kind of document | T |
(96) | European patent application number | 13737808.9 |
Date of filing the European patent application | 2013-06-21 | |
(97) | Date of publication of the European application | 2015-05-06 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/063004 |
Date | 2013-06-21 |
(87) | Number | WO 2014/005858 |
Date | 2014-01-09 |
(30) | Number | Date | Country code |
12174535 | 2012-07-01 | EP | |
201261694837 P | 2012-08-30 | US | |
12186781 | 2012-10-01 | EP | |
201261708162 P | 2012-10-01 | US |
(72) |
JENSEN, Christine Bj rn, DK
RASMUSSEN, Mads Frederik, DK
ZDRAVKOVIC, Milan, DK
KRISTENSEN, Peter, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | USE OF LONG-ACTING GLP-1 PEPTIDES |
USE OF LONG-ACTING GLP-1 PEPTIDES |